Inhibitory Effects of Devil's Claw (secondary Root of Harpagophytum Procumbens) Extract and Harpagoside on Cytokine Production in Mouse Macrophages
Affiliations
Successive oral administration (50 mg/kg) of a 50% ethanolic extract (HP-ext) of devil's claw, the secondary root of Harpagophytum procumbens, showed a significant anti-inflammatory effect in the rat adjuvant-induced chronic arthritis model. HP-ext dose-dependently suppressed the lipopolysaccharide (LPS)-induced production of inflammatory cytokines [interleukin-1beta (IL-1beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha)] in mouse macrophage cells (RAW 264.7). Harpagoside, a major iridoid glycoside present in devil's claw, was found to be one of the active agents in HP-ext and inhibited the production of IL-1beta, IL-6, and TNF-alpha by RAW 264.7.
Khumalo G, Loa-Kum-Cheung W, Van Wyk B, Feng Y, Cock I Inflammopharmacology. 2024; 32(2):1607-1620.
PMID: 38310564 PMC: 11006729. DOI: 10.1007/s10787-023-01420-9.
A Systemic Review on Nutraceutical Supplements used in the Management of Osteoarthritis.
Nooreen Z, Wal P, Summaiyya F Recent Adv Food Nutr Agric. 2024; 15(1):33-45.
PMID: 38258782 DOI: 10.2174/012772574X270405231102054920.
Quarta S, Santarpino G, Carluccio M, Calabriso N, Scoditti E, Siculella L Pharmaceuticals (Basel). 2022; 15(10).
PMID: 36297375 PMC: 9609228. DOI: 10.3390/ph15101263.
DNA Barcode Authentication of Devil's Claw Herbal Dietary Supplements.
Diaz-Silveira G, Deutsch J, Little D Plants (Basel). 2021; 10(10).
PMID: 34685813 PMC: 8540935. DOI: 10.3390/plants10102005.
From Bush Medicine to Modern Phytopharmaceutical: A Bibliographic Review of Devil's Claw ( spp.).
Brendler T Pharmaceuticals (Basel). 2021; 14(8).
PMID: 34451822 PMC: 8398729. DOI: 10.3390/ph14080726.